Please assess the completion status of the following clinical trial:

Trial Title: Azithromycin for Children Hospitalized With Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 4-12 years of age~* Admission diagnosis of asthma at the Children's Hospital at Montefiore~* History of persistent asthma (as defined by National Heart, Lung, and Blood Institute)~Exclusion Criteria:~* Concurrent bacterial infection requiring antibiotics~* Antibiotics received within previous 2 weeks~* Contraindication to azithromycin (including allergy to macrolides)~* Chronic lung disease other than asthma (including bronchopulmonary dysplasia, cystic fibrosis, bronchiectasis) or home oxygen requirement~* Immunodeficiency (primary or acquired)~* Chronic systemic steroid use~* Invasive or non-invasive mechanical ventilation required acutely as result of current asthma admission~* Significant cardiac co-morbidity (including hemodynamically significant cardiac disease or arrhythmia)~* Liver disease (hepatitis)~* Pregnancy~* Seizure disorder, currently on anti-epileptic medication)~* Receiving albuterol every 4 hours (q4h) at the time of enrollment~* Previous enrollment in study

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Azithromycin suspension (Type: EXPERIMENTAL): Azithromycin suspension at 10mg/kg/dose (max 500mg)~Once daily for 3 days
- Placebo suspension (Type: PLACEBO_COMPARATOR): Same volume as active drug~Once daily for 3 days

Based on this trial design, predict the completion outcome and termination type (if applicable).